 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Inhibrx Inc. (INBX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-08-21 Purchase | 2020-08-25 7:47 pm | Inhibrx Inc. | INBX | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC DRAGSA 50 LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 131,465 | $19.39 | $2,548,688 | 1,247,088 (Indirect) | View |
| 2020-08-26 Purchase | 2020-08-28 4:29 pm | Inhibrx Inc. | INBX | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Illiquid Investments Sub-Master LP Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities GP LLC DRAGSA 50 LLC HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner | 180,219 | $18.92 | $3,409,865 | 1,427,307 (Indirect) | View |
| 2021-02-16 Sale | 2021-02-18 5:06 pm | Inhibrx Inc. | INBX | Wagner Klaus W. Chief Medical Officer | 176,033 | $24.43 | $4,300,095 | 215,150 (Direct) | View |
| 2021-02-16 Sale | 2021-02-18 5:08 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 17,000 | $25.9 | $440,300 | 2,572,953 (Indirect) | View |
| 2021-03-24 Sale | 2021-03-24 7:12 pm | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 17,000 | $19.02 | $323,340 | 2,555,953 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-08-21 Option Award | 2020-08-21 4:24 pm | N/A 2030-08-20 | Inhibrx Inc. | INBX | MANHARD KIMBERLY Director | 17,259 | $0 | 17,259 (Direct) | View |
| 2020-08-21 Conversion | 2020-08-21 4:24 pm | N/A N/A | Inhibrx Inc. | INBX | FORSYTH DOUGLAS Director | 82,422 | $0 | 598,257 (Indirect) | View |
| 2020-08-21 Conversion | 2020-08-21 4:24 pm | N/A N/A | Inhibrx Inc. | INBX | FORSYTH DOUGLAS Director | 143,266 | $0 | 0 (Indirect) | View |
| 2020-08-21 Conversion | 2020-08-24 4:31 pm | N/A N/A | Inhibrx Inc. | INBX | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 2,129,003 | $0 | 2,129,003 (Indirect) | View |
| 2020-08-21 Conversion | 2020-08-24 4:31 pm | N/A N/A | Inhibrx Inc. | INBX | RA CAPITAL MANAGEMENT L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 3,700,634 | $0 | 0 (Indirect) | View |
| 2021-01-15 Gift | 2021-01-19 4:10 pm | N/A N/A | Inhibrx Inc. | INBX | Lappe Mark Lappe Family Trust CEO | 500,000 | $0 | 2,590,252 (Indirect) | View |
| 2021-01-15 Gift | 2021-01-19 4:10 pm | N/A N/A | Inhibrx Inc. | INBX | Lappe Mark Lappe Family Trust CEO | 500,000 | $0 | 500,000 (Indirect) | View |
| 2021-01-15 Option Award | 2021-01-19 4:10 pm | N/A 2031-01-15 | Inhibrx Inc. | INBX | Lappe Mark Lappe Family Trust CEO | 145,000 | $0 | 145,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-19 4:13 pm | N/A 2031-01-15 | Inhibrx Inc. | INBX | Deck Kelly CFO | 70,000 | $0 | 70,000 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-19 4:14 pm | N/A 2031-01-15 | Inhibrx Inc. | INBX | Wagner Klaus W. Chief Medical Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-01-15 Gift | 2021-01-19 4:16 pm | N/A N/A | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 160,000 | $0 | 2,589,953 (Indirect) | View |
| 2021-01-15 Gift | 2021-01-19 4:16 pm | N/A N/A | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 80,000 | $0 | 80,000 (Indirect) | View |
| 2021-01-15 Gift | 2021-01-19 4:16 pm | N/A N/A | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 80,000 | $0 | 80,000 (Indirect) | View |
| 2021-01-15 Option Award | 2021-01-19 4:16 pm | N/A 2021-01-15 | Inhibrx Inc. | INBX | Eckelman Brendan P. Eckelman Living Trust Dated February 5 2014 Chief Scientific Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-08 5:19 pm | N/A 2031-06-07 | Inhibrx Inc. | INBX | MANHARD KIMBERLY Director | 15,000 | $0 | 35,759 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-08 5:20 pm | N/A 2031-06-07 | Inhibrx Inc. | INBX | Kayyem Jon Faiz Director | 15,000 | $0 | 32,259 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-08 5:22 pm | N/A 2031-06-07 | Inhibrx Inc. | INBX | FORSYTH DOUGLAS Director | 15,000 | $0 | 32,259 (Direct) | View |